1. Intrafamilial and interfamilial heterogeneity of PINK1-associated Parkinson's disease in Sudan
- Author
-
Yousuf Bakhit, Mohamed O. Ibrahim, Christelle Tesson, Ali A. Elhassan, Mohamed Anwer Ahmed, Mohamed A. Alebeed, Salma M. Elrasheed, Mawia A. Omar, Rayan Abubaker, Khalid Eltom, Mutaz T. Shaheen, Yousuf A. Ibrahim, Murad E. Almak, Hiba A. Ali, Ahmed A. Abugrain, Mohamed A. Almahal, Abubaker A. MohamedSharif, Mohamed Y. Tahir, Sawazen M. Malik, Hazim Eldirdiri Abdelrahman, Reem J. Khidir, Malaz T. Mohamed, Abdelmohaymin Abdalla, Liena E.O. Elsayed, Suzanne Lesage, Jean-Christophe Corvol, Osheik Seidi, and Ullrich Wüllner
- Subjects
PINK1 ,Homozygote ,genetics [Protein Kinases] ,genetics [Mutation] ,Sudan ,Neurology ,genetics [Parkinson Disease] ,genetics [Parkinsonian Disorders] ,Humans ,ddc:610 ,Parkinson ,Neurology (clinical) ,Age of Onset ,Heterogeneity ,Geriatrics and Gerontology ,Protein Kinases - Abstract
PINK1 is the second most predominant gene associated with autosomal recessive Parkinson's disease. Homozygous mutations in this gene are associated with an early onset of symptoms. Bradykinesia, tremors, and rigidity are common features, while dystonia, motor fluctuation, and non-motor symptoms occur in a lower percentage of cases and usually respond well to levodopa. We investigated 14 individuals with parkinsonism and eleven symptom-free siblings from three consanguineous Sudanese families, two of them multigenerational, using a custom gene panel screening 34 genes, 27 risk variants, and 8 candidate genes associated with parkinsonism. We found a known pathogenic nonsense PINK1 variant (NM_032409.3:c.1366C>T; p.(Gln456*)), a novel pathogenic single base duplication (NM_032409.3:c.1597dup; p.(Gln533Profs*29)), and another novel pathogenic insertion (NM_032409.3:c.1448_1449ins[1429_1443; TTGAG]; p.(Arg483Serfs*7)). All variants were homozygous and co-segregated in all affected family members. We also identified intrafamilial and interfamilial phenotypic heterogeneity associated with PINK1 mutations in these Sudanese cases, possibly reflecting the nature of the Sudanese population that has a large effective population size, which suggests a higher possibility of novel findings in monogenic and polygenic diseases in Sudan.
- Published
- 2023